NeuroPace Inc
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Nov 10, 2026 (15 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 18, 2026 | Keybanc | initiate | — → Overweight | — | 53% |
| Jul 29, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Jul 23, 2026 | Mizuho | initiate | — → Outperform | — | 52% |
| May 15, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jan 27, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $19 | 44% |
| Dec 16, 2025 | UBS | maintain | Buy → Buy | $22 | 54% |
| Dec 10, 2025 | JP Morgan | maintain | Overweight → Overweight | $20 | 54% |
| Nov 5, 2025 | JP Morgan | maintain | Overweight → Overweight | $18 | 54% |
| Nov 5, 2025 | Wells Fargo | maintain | Overweight → Overweight | $16 | 54% |
| Aug 13, 2025 | Wells Fargo | maintain | Overweight → Overweight | $15 | 54% |
| May 28, 2025 | HC Wainwright & Co. | initiate | — → Buy | $18 | 44% |
| May 14, 2025 | JP Morgan | maintain | Overweight → Overweight | $16 | 54% |
| May 14, 2025 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $17 | 50% |
| Apr 14, 2025 | Cantor Fitzgerald | maintain | Overweight → Overweight | $17 | 50% |
| Mar 5, 2025 | Cantor Fitzgerald | maintain | Overweight → Overweight | $20 | 50% |
| Jan 30, 2025 | Wells Fargo | maintain | Overweight → Overweight | $17 | 54% |
| Jan 21, 2025 | UBS | initiate | — → Buy | $17 | 54% |
| Dec 17, 2024 | JP Morgan | maintain | Overweight → Overweight | $14 | 54% |
| Nov 13, 2024 | Wells Fargo | maintain | Overweight → Overweight | $13 | 54% |
| Aug 14, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $18 | 50% |
| Aug 14, 2024 | Wells Fargo | maintain | Overweight → Overweight | $15 | 54% |
| Jul 15, 2024 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $8 | 54% |
| May 9, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $18 | 50% |
| Mar 14, 2024 | Wells Fargo | upgrade | Equal-Weight → Overweight | $20 | 54% |
| Mar 12, 2024 | JP Morgan | maintain | Overweight → Overweight | $17 | 54% |
| Mar 6, 2024 | Cantor Fitzgerald | maintain | Overweight → Overweight | $18 | 50% |
| Mar 6, 2024 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $13 | 54% |
| Feb 22, 2024 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $16 | 54% |
| Jan 30, 2024 | Leerink Partners | initiate | — → Outperform | $22 | 51% |
| Dec 27, 2023 | Lake Street | reiterate | Buy → Buy | $12 | 47% |
| Dec 4, 2023 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $9 | 54% |
| Nov 14, 2023 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $8 | 54% |
| Nov 10, 2023 | Cantor Fitzgerald | initiate | — → Overweight | $11 | 50% |
| Nov 7, 2023 | JP Morgan | maintain | Overweight → Overweight | $9 | 54% |
| Oct 4, 2023 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $9 | 54% |
| Aug 24, 2023 | Morgan Stanley | upgrade | Underweight → Equal-Weight | $6 | 54% |
| May 5, 2023 | Morgan Stanley | maintain | — → Underweight | $5 | 54% |
| Mar 3, 2023 | Morgan Stanley | maintain | — → Underweight | $4.5 | 54% |
| Feb 22, 2023 | Lake Street | initiate | — → Buy | $10 | 47% |
| Jan 6, 2023 | Morgan Stanley | maintain | — → Underweight | $2.5 | 54% |
| Oct 11, 2022 | Morgan Stanley | maintain | — → Underweight | $3.5 | 54% |
| Jul 15, 2022 | Morgan Stanley | maintain | — → Underweight | $5.5 | 54% |
| May 13, 2022 | Morgan Stanley | maintain | — → Underweight | $6 | 54% |
| May 13, 2022 | Wells Fargo | maintain | — → Equal-Weight | $6 | 54% |
| Apr 6, 2022 | Wolfe Research | initiate | — → Outperform | $13 | 53% |
| Mar 11, 2022 | Wells Fargo | maintain | — → Equal-Weight | $9 | 54% |
| Mar 11, 2022 | SVB Leerink | maintain | — → Outperform | $12 | — |
| Jan 19, 2022 | Wells Fargo | downgrade | Overweight → Equal-Weight | $11 | 54% |
| Jan 7, 2022 | Morgan Stanley | downgrade | Equal-Weight → Underweight | $12 | 54% |
| Aug 18, 2021 | Baird | initiate | — → Outperform | $26 | 55% |
No cross-platform signals in the last 90 days